The Flu Vaccine

[Guest guest]

In 2001, just 257 people died from the flu. (Fifty-nine percent of

these deaths occurred in people 75 years or older; 75 percent

occurred in people 55 years or older.) To put these numbers in

perspective, 3,454 Americans died from malnutrition in 2001.

http://thinktwice.com/cdc_2001.pdf

Currently, the CDC has responsibility for both vaccine safety and

promotion, which is an inherent conflict of interest increasingly

garnering public criticism.

http://weldon.house.gov/News/Documen...cumentID=47773

The CDC Foundation was established to connect outside partners and

resources with CDC scientists to build programs that can

substantially enhance CDC's impact. [its a conflict of interest to

have a for profit corporation tell American people what vaccines

they should be taking]

http://www.cdcfoundation.org/partner...ons/index.aspx

[Guest guest]

That first site has a lot of articles in it written by the Geiers. There was an interesting piece on them regarding their 'analysis' of the VAERS reports. Seems they wrote up the adverse reactions as though the 'cause and effect' of the reaction had been proven as fact when it clearly states on VAERS site that ALL adverse reactions that happen after a vaccination are accepted, this does not mean it was the vaccine that caused the reaction.. just means a reaction was reported.

"When evaluating data from VAERS, it is important to note that for any reported event, no cause and effect relationship has been established. VAERS is interested in all potential associations between vaccines and adverse events. Therefore, VAERS collects data on any adverse event following vaccination, be it coincidental or truly caused by a vaccine. The report of an adverse event to VAERS is not documentation that a vaccine caused the event."

http://vaers.hhs.gov/info.htm

There are a lot more details on their page.

Some interesting reading regarding the Geir's.... http://casewatch.org/civil/geier.shtml

http://photoninthedarkness.blogspot.com/2005/07/dumpster-diving-republished.html

Carol in IL

Mom to seven including , 6 with TOF, AVcanal, GERD, LS, Asthma, subglottal stenosis, chronic constipation ( cured now ) and DS.

My problem is not how I look. It's how you see me.

The Flu Vaccine

Some interesting links to info about the flu vaccine -

http://www.nccn. net/~wwithin/ flu.htm

http://www.whale. to/vaccines/ flu.html - this one has package inserts on it.

http://www.planetc1 .com/cgi- bin/n/v.cgi? c=1 & id=1163608370

Flu Vaccine increases risk for neurological disorderplanetc1.com- news@5:32 am PST by Dorausch, DCplanetc1.com news staff

It is important to be aware of the risks involved when considering taking any drug or vaccine or putting a drug or vaccine into a young ones body. A new study has revealed that the flu vaccine is associated with an increased risk of developing a debilitating neurological disorder known as Guillain-Barré syndrome.

The debilitating nerve destroying syndrome affects about one in 100,000 people each year. It results from the body's immune system attacking parts of the nervous system, causing weakness or tingling that can eventually lead to paralysis. Previous research had linked Guillain-Barré syndrome to the flu vaccine, but researchers continue to look for more connections between debilitating conditions and flu vaccines.

According to the National Institute of Neurological Disorders and Stroke, Guillain-Barré (ghee-yan bah-ray) syndrome is a disorder in which the body's immune system attacks part of the peripheral nervous system. The first symptoms of this disorder include varying degrees of weakness or tingling sensations in the legs. In many instances the weakness and abnormal sensations spread to the arms and upper body. These symptoms can increase in intensity until certain muscles cannot be used at all and, when severe, the patient is almost totally paralyzed.

The research comes from the University of Toronto. Researchers studied residents in Ontario, where a flu vaccine immunization program was started in 2000. All Ontario residents 6 months or older received a FREE flu vaccine. Researchers looked into cases of hospitalization for Guillain-Barré syndrome from 1993 to 2004. They then researched who had received a flu vaccine and compared the individuals risk for the syndrome within two to seven weeks after vaccination up to twenty to forty-three weeks later. Researchers also compared the number of Guillain-Barré cases before and after the immunization program began in 2000.

Researchers discovered that Ontario residents were more likely to be hospitalized for Guillain-Barré syndrome in the two to seven weeks after being vaccinated than at forty-three weeks. It showed a small but increased risk for the disease after vaccination.

There has been a lot of discussion whether the flu vaccine is even effective in preventing the flu. Add to that, the risk of developing disabling nerve disorders, mercury toxicity (from shots containing thimerosal), as well as other side effects, and you may wonder we one would even subject themselves to the shot. One thing is for sure, the more people that get the flu shot, the more data researchers will have to determine what disorders and conditions are caused by the shot.

-- Doing a pubmed search for "Guillain-Barré syndrome flu vaccine" yielded these results:

A case of influenza vaccination induced Guillain Barre syndrome with normal cerebrospinal fluid protein and improvement on treatment with corticosteroids.

Eckert T,

Bartels C,

Mawrin C,

Feistner H,

Welte T.

Department of Pneumology, Medical School of Hannover, Carl-Neuberg- Str. 1, 30625 Hannover, Germany.

We report a case of a 62-y-old male developing an influenza vaccination induced Guillain Barre syndrome (GBS) showing all clinical and neuropathological symptoms of GBS except the characteristic elevation of protein levels in the cerebrospinal fluid. The patient improved under treatment with 100 mg prednisolone. In these cases the administration of corticosteroids might be considered as a treatment option as they might represent a subgroup of GBS with a different immunological response pattern.

PMID: 16138440 [PubMed - indexed for MEDLINE]

-----

Guillain-Barre syndrome following influenza vaccination.

Haber P,

DeStefano F,

Angulo FJ,

Iskander J,

Shadomy SV,

Weintraub E,

Chen RT.

Immunization Safety Branch, Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Ga 30333, USA. PHaber@...

CONTEXT: An unexplained increase in the risk of Guillain-Barre syndrome (GBS) occurred among recipients of the swine influenza vaccine in 1976-1977. Guillain-Barre syndrome remains the most frequent neurological condition reported after influenza vaccination to the Vaccine Adverse Events Reporting System (VAERS) since its inception in 1990. OBJECTIVE: To evaluate trends of reports to VAERS of GBS following influenza vaccination in adults. DESIGN, SETTING, AND PARTICIPANTS: VAERS is the US national spontaneous reporting system for adverse events following vaccination. Reports of GBS in persons 18 years or older following influenza vaccination were evaluated for each influenza season from July 1, 1990, through June 30, 2003. The number of people vaccinated was estimated from the National Health Interview Survey and US census data. Beginning in 1994, active follow-up was conducted to verify GBS diagnosis and obtain other clinical details. MAIN OUTCOME

MEASURE: Reporting rates of GBS following influenza vaccination over time. RESULTS: From July 1990 through June 2003, VAERS received 501 reports of GBS following influenza vaccination in adults. The median onset interval (13 days) was longer than that of non-GBS reports of adverse events after influenza vaccine (1 day) (P<.001). The annual reporting rate decreased 4-fold from a high of 0.17 per 100,000 vaccinees in 1993-1994 to 0.04 in 2002-2003 (P<.001). A GBS diagnosis was confirmed in 82% of reports. Preceding illness within 4 weeks of vaccination was identified in 24% of reported cases. CONCLUSIONS: From 1990 to 2003, VAERS reporting rates of GBS after influenza vaccination decreased. The long onset interval and low prevalence of other preexisting illnesses are consistent with a possible causal association between GBS and influenza vaccine. These findings require additional research, which can lead to a fuller understanding of the causes of GBS and its possible

relationship with influenza vaccine.

PMID: 15562126 [PubMed - indexed for MEDLINE]

---

Influenza vaccination and Guillain Barre syndrome small star, filled.

Geier MR,

Geier DA,

Zahalsky AC.

The Genetic Centers of America, 14 Redgate Court, Silver Spring, MD 20905, USA. mgeiererols (DOT) com <mgeiererols (DOT) com>

Acute and severe Guillain Barre Syndrome (GBS) cases reported following influenza vaccine to the Vaccine Adverse Events Reporting System (VAERS) database from 1991 through 1999 were examined. Endotoxin concentrations were measured using the Limulus amebocyte lysate assay in influenza vaccines. There were a total of 382 cases of GBS reported to the VAERS database following influenza vaccination (male/female ratio, 1.2). The median onset of GBS following influenza vaccine was 12 days (interquartile range, 7 days to 21 days). There was an increased risk of acute GBS (relative risk, 4.3; 95% confidence interval, 3.0 to 6.4) and severe GBS (relative risk, 8.5; 95% confidence interval, 3.7 to 18.9) in comparison to an adult tetanus-diphtheria (Td) vaccine control group. There were maximums in the incidence of GBS following influenza vaccine that occurred approximately every third year (1993, 1996, and 1998) and statistically significant variation in the

incidence of GBS among different influenza manufacturers. Influenza vaccines contained from a 125- to a 1250-fold increase in endotoxin concentrations in comparison to an adult Td vaccine control and endotoxin concentrations varied up to 10-fold among different lots and manufacturers of influenza vaccine. The biologic mechanism for GBS following influenza vaccine may involve the synergistic effects of endotoxin and vaccine-induced autoimmunity. There were minimal potential reporting biases in the data reported to the VAERS database in this study. Patients should make an informed consent decision on whether to take this optional vaccine based upon its safety and efficacy and physicians should vigilantly report GBS following influenza vaccination to the VAERS in the United States so that continued evaluation of the safety of influenza vaccine may be undertaken.

PMID: 12763480 [PubMed - indexed for MEDLINE]

Qadoshyah

Sponsored Link$420,000 Mortgage for $1,399/month - Think You Pay Too Much For Your Mortgage? Find Out!